Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Johnson Yiu-Nam Lau"'
Autor:
Lixiang Zhai, Haitao Xiao, Chengyuan Lin, Hoi Leong Xavier Wong, Yan Y. Lam, Mengxue Gong, Guojun Wu, Ziwan Ning, Chunhua Huang, Yijing Zhang, Chao Yang, Jingyuan Luo, Lu Zhang, Ling Zhao, Chenhong Zhang, Johnson Yiu-Nam Lau, Aiping Lu, Lok-Ting Lau, Wei Jia, Liping Zhao, Zhao-Xiang Bian
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract The incidence of metabolic syndrome is significantly higher in patients with irritable bowel syndrome (IBS), but the mechanisms involved remain unclear. Gut microbiota is causatively linked with the development of both metabolic dysfunctions
Externí odkaz:
https://doaj.org/article/4761893c769046958a1acdec4f252085
Publikováno v:
MedComm – Future Medicine, Vol 1, Iss 1, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/12dc2b09be6a49c9a1c9f9f28ce89f99
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-14 (2021)
Abstract Since the first description of a coronavirus-related pneumonia outbreak in December 2019, the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a pandemic, and as of today, >100 million people globally in over 21
Externí odkaz:
https://doaj.org/article/9346806226ff4e269c7728df8890588f
Autor:
Zhongcheng Zhou, Peng Du, Meixing Yu, Daniel T. Baptista-Hon, Man Miao, Andy P. Xiang, Johnson Yiu-Nam Lau, COVID-19 Immunity Investigation Group, Gen Li, Kang Zhang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/ecd18e8067e948aca89f5bd306d21521
Autor:
Shuofeng Yuan, Hin Chu, Jasper Fuk-Woo Chan, Zi-Wei Ye, Lei Wen, Bingpeng Yan, Pok-Man Lai, Kah-Meng Tee, Jingjing Huang, Dongdong Chen, Cun Li, Xiaoyu Zhao, Dong Yang, Man Chun Chiu, Cyril Yip, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Kong-Hung Sze, Jie Zhou, Ivy Hau-Yee Chan, Kin-Hang Kok, Kelvin Kai-Wang To, Richard Yi-Tsun Kao, Johnson Yiu-Nam Lau, Dong-Yan Jin, Stanley Perlman, Kwok-Yung Yuen
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
Viruses rely on host cell metabolism for replication, making these pathways potential therapeutic targets. Here, the authors show that AM580, a retinoid derivative and RAR-α agonist, affects replication of several RNA viruses by interfering with the
Externí odkaz:
https://doaj.org/article/c1c5fe348ab54b8eb38874751717d9b6
Autor:
Kuo-Ming, Yu, Ping, Yang, Tien-Yu, Huang, Thomas Yen-Shih, Shen, Johnson Yiu-Nam, Lau, Oliver Yoa-Pu, Hu
Publikováno v:
Analytical and Bioanalytical Chemistry. 414:4067-4077
Liver disease has emerged as a healthcare burden because of high hospitalization rates attributed both to steatohepatitis and to severe hepatic toxicity associated with changes of drug exposure. Early detection of hepatic insufficiency is critical to
Autor:
Lixiang Zhai, Chunhua Huang, Ziwan Ning, Yijing Zhang, Min Zhuang, Wei Yang, Xiaolei Wang, Jingjing Wang, Eric Lu Zhang, Haitao Xiao, Ling Zhao, Yan Y Lam, Chi-Fung Willis Chow, Jiandong Huang, Shuofeng Yuan, Kui-Ming Chan, Chun-Su Yuan, Johnson Yiu-Nam Lau, Hoi-Leong Xavier Wong, Zhao-Xiang Bian
Publikováno v:
Basic Gastroenterology.
Autor:
Peng Du, Man Miao, Kang Zhang, Andy Peng Xiang, Meixing Yu, Zhongcheng Zhou, Daniel T. Baptista-Hon, Gen Li, Johnson Yiu-Nam Lau
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Autor:
Lixiang Zhai, Chunhua Huang, Ziwan Ning, Yijing Zhang, Min Zhuang, Wei Yang, Xiaolei Wang, Jingjing Wang, Lu Zhang, Haitao Xiao, Ling Zhao, Pallavi Asthana, Yan Y. Lam, Chi Fung Willis Chow, Jian-dong Huang, Shuofeng Yuan, Kui Ming Chan, Chun-Su Yuan, Johnson Yiu-Nam Lau, Hoi Leong Xavier Wong, Zhao-xiang Bian
Publikováno v:
Cell hostmicrobe.
Diarrhea-predominant irritable bowel syndrome (IBS-D), a globally prevalent functional gastrointestinal (GI) disorder, is associated with elevated serotonin that increases gut motility. While anecdotal evidence suggests that the gut microbiota contri
Publikováno v:
Precision Clinical Medicine
The SARS-CoV-2 Delta variant has evolved as the dominant strain of the current pandemic. Studies have shown that this variant has increased infectivity/viral load, and reduced neutralization by the host antibodies from convalescent patients/vaccinees